New therapies increase survival rates in post-transplant liver cancer patients, study suggests
Thursday, March 25, 2010 - 10:29
in Health & Medicine
A recent study found that sirolimus-based immunosuppression following liver transplantation in patients with non-resectable hepatocellular carcinoma (liver cancer) significantly increases survival rates for this patient population.